Yangyang Jiang

Dr. Yangyang Jiang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2023 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
FFFan Fei
Fan Fei
TWTao Wang
Tao Wang
YJYangyang Jiang
Yangyang Jiang
XCXiaoling Chen
Xiaoling Chen
CMChengbang Ma
Chengbang Ma
LWLei Wang
Lei Wang
Staphylococcus aureus (S. aureus), one of the most prevalent bacteria found in atopic dermatitis lesions, can induce ongoing infections and inflammation by downregulating the expression of host defence peptides in the skin. In addition, the emergence of the ‘superbug’ Methicillin‐resistant S. aureus (MRSA) has made the treatment of these infections more challenging. Antimicrobial peptides (AMPs), due to their potent antimicrobial activity, limited evidence of resistance development, and potential immunomodulatory effects, have gained increasing attention as potential therapeutic agents for atopic dermatitis. In this study, we report a novel AMP, brevinin‐1E‐OG9, isolated from the skin secretions of Odorrana grahami, which shows potent antibacterial activity, especially against S. aureus. Based on the characteristics of the ‘Rana Box’, we designed a set of brevinin‐1E‐OG9 analogues to explore its structure–activity relationship. Brevinin‐1E‐OG9c‐De‐NH2 exhibited the most potent antimicrobial efficacy in both in vitro and ex vivo studies and attenuated inflammatory responses induced by lipoteichoic acid and heat‐killed microbes. As a result, brevinin‐1E‐OG9c‐De‐NH2 might represent a promising candidate for the treatment of S. aureus skin infections.

12 November 2022 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
WZWanchen Zou
Wanchen Zou
YZYingqi Zhang
Yingqi Zhang
MZMei Zhou
Mei Zhou
XCXiaoling Chen
Xiaoling Chen
CMChengbang Ma
Chengbang Ma
LWLei Wang
Lei Wang
• A naturally-occurring antimicrobial peptide palustrin- 2LTb was firstly identified from frog secretion of Kuatun frog, Hylarana latouchii. • Using trypsin as a model protease to intercept the long-chain template peptide. • Bioinformatics-aided approach explores the valid fragments and evaluates binding affinity. • Removal of ‘Rana-Box’ in palustrin-2LTb greatly decreases the haemolysis of peptide and improves selectivity. • The fragments 3 showed great in vivo therapeutic potential in the MRSA-infected wax worm model.

29 May 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
YLYaxian Lin
Yaxian Lin
YJYangyang Jiang
Yangyang Jiang
ZZZiwei Zhao
Ziwei Zhao
YLYueyang Lu
Yueyang Lu
XXXinping Xi
Xinping Xi
LWLei Wang
Lei Wang
Bacterial resistance against antibiotics has led to increasing numbers of treatment failures, and AMPs are widely accepted as becoming potential alternatives due to their advantages. Temporin-PKE is a novel peptide extracted from the skin secretion of Pelophylax kl. esculentus and it displays a strong activity against Gram-positive bacteria, with an extreme cytotoxicity. Incorporating positively charged residues and introducing D-amino acids were the two main strategies adopted for the modifications. The transformation of the chirality of Ile could reduce haemolytic activity, and an analogue with appropriate D-isoforms could maintain antimicrobial activity and stability. The substitution of hydrophobic residues could bring about more potent and broad-spectrum antimicrobial activities. The analogues with Lys were less harmful to the normal cells and their stabilities remained at similarly high levels compared to temporin-PKE. The optimal number of charges was three, and the replacement on the polar face was a better choice. Temporin-PKE-3K exerted dually efficient functions includingstrong antimicrobial and anticancer activity. This analogue showed a reduced possibility for inducing resistance in MRSA and Klebsiella pneumoniae, a rather strong antimicrobial activity in vivo, and it exhibited the highest therapeutic index such that temporin-PKE-3K has the potential to be developed as a clinical drug.

1 January 2023 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
WZWanchen Zou
Wanchen Zou
RSRuize Sun
Ruize Sun
AYAifang Yao
Aifang Yao
MZMei Zhou
Mei Zhou
XCXiaoling Chen
Xiaoling Chen
LWLei Wang
Lei Wang
In recent decades, antimicrobial peptides (AMPs) have held great promise as novel antibiotic agents. However, they have generally been excluded from clinical use due to certain limitations, such as poor biocompatibility and sensitivity to environmental conditions. In this study, we report a novel brevinin-1 type antimicrobial peptide B1LTe, derived from the skin secretion of Hylarana latouchii. Although the novel peptide B1LTe exhibited remarkable antimicrobial effects, its narrow therapeutic index (TI) can result in adverse drug reactions. Thus, the rational design by systematically scanning and replacing the inherent hydrophobic and cationic residues (Leucine and Lysine) with their D-enantiomeric counterparts was conducted to enhance the application potential of B1LTe. Simultaneously, we also applied lysine-to-arginine substitution within the modification. Among the derivates, 5 R demonstrated the highest selectivity and effectiveness against Methicillin-resistant Streptococcus aureus (MRSA), clinic-isolated Streptococcus pyogenes (S. pyogenes) strain, ranging from their planktonic to biofilm cells, both in vitro and in vivo. Furthermore, the remarkable adaptation of 5 R in saline and 20% serum indicates its potential for clinical application. We employed the in silico approach, which revealed the mechanism of interaction between 5 R and bacterial membranes. In addition, further mechanistic studies of 5 R elucidated the association between the collapsed proton motive force (PMF) and membrane perturbation as peptides aggregate on the bacterial membrane. Overall, our study suggests the D-enantiomeric 5 R can be a promising antibiotic agent against MDR bacteria in further clinical development and highlights the significance of cellular PMF as a potential target for the research of peptides’ mode of action.

11 September 2023 in Molecules
Verified
Journal Article
Open access
PDF file
XMXiaonan Ma
Xiaonan Ma
YCYuping Chen
Yuping Chen
ASAnmei Shu
Anmei Shu
YJYangyang Jiang
Yangyang Jiang
XCXiaoling Chen
Xiaoling Chen
LWLei Wang
Lei Wang
The emergence of multidrug-resistant bacteria has severely increased the burden on the global health system, and such pathogenic infections are considered a great threat to human well-being. Antimicrobial peptides, due to their potent antimicrobial activity and low possibility of inducing resistance, are increasingly attracting great interest. Herein, a novel dermaseptin peptide, named Dermaseptin-SS1 (SS1), was identified from a skin-secretion-derived cDNA library of the South/Central American tarsier leaf frog, Phyllomedusa tarsius, using a ‘shotgun’ cloning strategy. The chemically synthesized peptide SS1 was found to be broadly effective against Gram-negative bacteria with low haemolytic activity in vitro. A designed synthetic analogue of SS1, named peptide 14V5K, showed lower salt sensitivity and more rapid bacteria killing compared to SS1. Both peptides employed a membrane-targeting mechanism to kill Escherichia coli. The antiproliferative activity of SS1 and its analogues against lung cancer cell lines was found to be significant.

19 February 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
FLFengting Liao
Fengting Liao
YCYuping Chen
Yuping Chen
ASAnmei Shu
Anmei Shu
XCXiaoling Chen
Xiaoling Chen
TWTao Wang
Tao Wang
LWLei Wang
Lei Wang
The rational design modification of membrane-active peptide structures by introducing additional membrane-penetrating regions has become a good strategy for the improvement of action and potency. Aurein 1.2 (GLFDIIKKIAESF-NH2) is a multifunctional antimicrobial peptide isolated from the green and golden bell frog, Litoria aurea, and the southern bell frog Litoria raniformis skin secretions. Its bio-functionality has been widely investigated. However, its lack of a potent action failed to provide aurein 1.2 with a competitive edge for further development as a therapeutic agent for clinical use. Herein, aurein 1.2 was chosen as a template for rational modification to achieve a more potent bio-functionality. KLA-2 (GLFDIIKKLAKLAESF-NH2), which a double KLA region inserted into the sequence, presented a 2–16-fold enhancement of antimicrobial activity, a 2–8-fold greater anti-biofilm activity (including biofilm prevention and eradication), and a 7-fold more potent anti-proliferation activity and hence was regarded as the most broad-spectrum active peptide. Additionally, with respect to antimicrobial activity, the IIKK-modified analog, IK-3 (GLFDIIKKIIKKIIKKI-NH2), also demonstrated a potent enhancement of activity against various pathogens, exhibiting a 2–8-fold enhanced activity compared to the parent peptide. Moreover, the selectivities of KLA-1 and KLA-2 were enhanced significantly. In conclusion, peptide modification, through the introduction of additional membrane penetrating regions, can increase both the potency and activity spectra of natural template peptides, making them suitable candidates for new drug development.